Citadel Advisors - CNS PHARMACEUTICALS INC ownership

CNS PHARMACEUTICALS INC's ticker is CNSP and the CUSIP is 18978H102. A total of 21 filers reported holding CNS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of CNS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$6,000
-66.7%
20,721
-62.5%
0.00%
Q1 2022$18,000
-69.0%
55,231
-32.6%
0.00%
Q4 2021$58,000
+81.2%
81,934
+286.2%
0.00%
Q3 2021$32,000
-85.5%
21,213
-77.0%
0.00%
Q1 2021$221,00092,4040.00%
Other shareholders
CNS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Virtu Financial LLC 20,745$41,0000.00%
Integrated Advisors Network LLC 10,700$21,0000.00%
Alpha Cubed Investments, LLC 11,000$22,0000.00%
Renaissance Technologies 432,109$847,0000.00%
TWO SIGMA SECURITIES, LLC 11,061$22,0000.00%
Sterling Financial Planning, Inc. 600$1,0000.00%
UBS Group AG 4,676$9,0000.00%
Capital Analysts, LLC 1,000$2,0000.00%
OSAIC HOLDINGS, INC. 5,000$10,0000.00%
BANK OF AMERICA CORP /DE/ 2,000$4,0000.00%
View complete list of CNS PHARMACEUTICALS INC shareholders